SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-062676
Filing Date
2023-05-19
Accepted
2023-05-19 16:06:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 tm2316056-1_s1.htm S-1 773685
2 EXHIBIT 21.1 tm2316056d2_ex21-1.htm EX-21.1 1183
3 EXHIBIT 23.1 tm2316056d2_ex23-1.htm EX-23.1 2432
4 EX-FILING FEES tm2316056d2_ex-filingfees.htm EX-FILING FEES 28098
5 GRAPHIC lg_transcodethera-4c.jpg GRAPHIC 43878
6 GRAPHIC fc_modular-4c.jpg GRAPHIC 211980
  Complete submission text file 0001104659-23-062676.txt   1140740
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272082 | Film No.: 23940064
SIC: 2834 Pharmaceutical Preparations